Resting human peripheral blood lymphocytes can be activated to cytolytic function by antibodies to CD3 in the absence of exogenous interleukin-2
- 1 July 1988
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 114 (2), 370-384
- https://doi.org/10.1016/0008-8749(88)90329-2
Abstract
No abstract availableThis publication has 71 references indexed in Scilit:
- Lymphokine-activated killer cell activity: Characteristics of effector cells and their progenitors in blood and spleenImmunology Today, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Requirements for activation of human peripheral blood T cells by mouse monoclonal antibodies to CD3Clinical Immunology and Immunopathology, 1987
- The T-cell receptor-T3 complex and T-lymphocyte activationHuman Immunology, 1987
- Enhancement of natural killer function through activation of the T11 E rosette receptor.Journal of Clinical Investigation, 1987
- The pharmacokinetics and toxicity of murine monoclonal antibodies and of gelonin conjugates of these antibodiesInternational Journal of Immunopharmacology, 1987
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Use of anti-receptor antibodies to focus T-cell activityImmunology Today, 1986
- A monoclonal antibody to human acute lymphoblastic leukaemia antigenNature, 1980